BIOL - .15 Pre-market at .2453/.2456 Biolase Anticipates Q1 Net Revenue To Exceed $10M, Relatively Flat Y/Y (Est $10.796M); 2024 Net Revenue To Increase 6%-8% To $52M-$53M (Est $53.068M)